Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome.
Vicente A, Patel BA, Gutierrez-Rodrigues F, Groarke E, Giudice V, Lotter J, Feng X, Kajigaya S, Weinstein B, Barranta E, Olnes MJ, Parikh AR, Albitar M, Wu CO, Shalhoub R, Calvo KR, Townsley DM, Scheinberg P, Dunbar CE, Young NS, Winkler T. Vicente A, et al. Among authors: parikh ar. Haematologica. 2020 Dec 1;105(12):2785-2794. doi: 10.3324/haematol.2020.249995. Haematologica. 2020. PMID: 33256377 Free PMC article.
Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE. Olnes MJ, et al. Among authors: parikh ar. N Engl J Med. 2012 Jul 5;367(1):11-9. doi: 10.1056/NEJMoa1200931. N Engl J Med. 2012. PMID: 22762314 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 32439728
Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab.
Lai C, Ranpura V, Wu C, Olnes MJ, Parikh AR, Shenoy A, Thompson J, Weinstein B, Scheinberg P, Barrett AJ, Desmond R, Young NS, Hourigan CS. Lai C, et al. Among authors: parikh ar. Blood Adv. 2019 Apr 9;3(7):980-983. doi: 10.1182/bloodadvances.2018030411. Blood Adv. 2019. PMID: 30936058 Free PMC article. No abstract available.
Guiding Principles for Community Building in Global Oncology.
Abuali I, Mathew A, Rugengamanzi E, Sainamthip P, Verduzco-Aguirre H, Parikh AR. Abuali I, et al. Among authors: parikh ar. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e100045. doi: 10.1200/EDBK_100045. Am Soc Clin Oncol Educ Book. 2024. PMID: 38768401 Free article. Review.
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
Lee G, Kim DW, Smart AC, Horick NK, Eyler CE, Roberts HJ, Pathak P, Goyal L, Franses J, Heather JM, Hwang WL, Grassberger C, Klempner SJ, Drapek LC, Allen JN, Blaszkowsky LS, Parikh AR, Ryan DP, Clark JW, Hong TS, Wo JY. Lee G, et al. Among authors: parikh ar. Am J Clin Oncol. 2024 May 20. doi: 10.1097/COC.0000000000001108. Online ahead of print. Am J Clin Oncol. 2024. PMID: 38767086
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
Parikh AR, Chee BH, Tsai J, Rich TA, Price KS, Patel SA, Zhang L, Ibrahim F, Esquivel M, Van Seventer EE, Jarnagin JX, Raymond VM, Corvera CU, Hirose K, Nakakura EK, Corcoran RB, Van Loon K, Atreya CE. Parikh AR, et al. Clin Cancer Res. 2024 May 2. doi: 10.1158/1078-0432.CCR-23-3660. Online ahead of print. Clin Cancer Res. 2024. PMID: 38695832
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India.
Mathew A, Davis S, Boby JM, R I A, Suryavanshi M, Dawood SS, Panda PK, Nag SM, Das A, Rohatgi N, Popat S, Shah RNH, Thampy C, Parikh AR, Yadav S, Mehta P, Singh R, Mukherji D, Shilpakar R, Mullapally SK, Sirohi B. Mathew A, et al. Among authors: parikh ar. JCO Glob Oncol. 2024 Mar;10:e2300330. doi: 10.1200/GO.23.00330. JCO Glob Oncol. 2024. PMID: 38484196 Free PMC article.
99 results